STOCK TITAN

[Form 4] SUI Group Holdings Ltd. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

SUI Group Holdings Ltd. director Liszt Howard P received a one-time equity grant in the form of four warrant awards, effective July 6, 2026, as part of non-management director compensation. The grants cover an aggregate of 83,026 underlying common shares at exercise prices between $5.42 and $7.046 per share, with no cash paid for the awards themselves.

The warrants vest in four equal installments: 25% of each tranche becomes exercisable on January 6, 2027, a further 25% on July 6, 2027, another 25% on January 6, 2028, and the final 25% on July 6, 2028. Expiration dates fall in 2031, giving the director several years to choose when to exercise after vesting.

Positive

  • None.

Negative

  • None.
Insider LISZT HOWARD P
Role null
Type Security Shares Price Value
Grant/Award Warrant for common stock 33,211 $0.00 --
Grant/Award Warrant for common stock 16,605 $0.00 --
Grant/Award Warrant for common stock 16,605 $0.00 --
Grant/Award Warrant for common stock 16,605 $0.00 --
Holdings After Transaction: Warrant for common stock — 33,211 shares (Direct, null)
Footnotes (1)
  1. Represents a one-time equity grant as part of the Reporting Person's non-management director compensation, effective July 6, 2026. The warrants vest as follows: 25% of each tranche of the warrants become exercisable on January 6, 2027, 25% of each tranche of the warrants will become exercisable on July 6, 2027, 25% of each tranche of the warrants will become exercisable on January 6, 2028, and 25% of each tranche of the warrants will become exercisable on July 6, 2028.
Total underlying shares 83,026 shares Aggregate underlying common stock for all warrant grants effective July 6, 2026
First warrant tranche 16,605 shares at $7.046 Warrant for common stock, exercise price $7.046 per share
Second warrant tranche 16,605 shares at $6.504 Warrant for common stock, exercise price $6.504 per share
Third warrant tranche 16,605 shares at $5.962 Warrant for common stock, exercise price $5.962 per share
Fourth warrant tranche 33,211 shares at $5.42 Largest warrant tranche, exercise price $5.42 per share
Vesting schedule 4 installments of 25% Vests on Jan 6, 2027; Jul 6, 2027; Jan 6, 2028; Jul 6, 2028
Expiration dates 2031 Three tranches expire Jan 6, 2031; one expires Jul 6, 2031
Grant price per warrant $0.00 No cash paid for the warrant grants on award date
Warrant for common stock financial
"security_title: "Warrant for common stock" for each derivative grant"
non-management director compensation financial
"Represents a one-time equity grant as part of the Reporting Person's non-management director compensation"
tranche financial
"The warrants vest as follows: 25% of each tranche of the warrants become exercisable"
A tranche is one slice of a larger financing or investment that is released, sold, or paid out in separate parts rather than all at once. Investors care because each slice can carry different risk, return and timing—like buying pieces of a cake where some slices are richer or come later—so the specific tranche you hold affects when you get paid and how much you might gain or lose.
vest financial
"The warrants vest as follows: 25% of each tranche of the warrants become exercisable"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
expiration date financial
"expiration_date: "2031-01-06T00:00:00.000Z" and "2031-07-06T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LISZT HOWARD P

(Last)(First)(Middle)
130 LAKE STREET W, SUITE 300

(Street)
WAYZATA MINNESOTA 55391

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
SUI Group Holdings Ltd. [ SUIG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrant for common stock$5.4207/06/2026A33,211(1) (2)07/06/2031Common stock33,211$033,211D
Warrant for common stock$5.96207/06/2026A16,605(1) (2)01/06/2031Common stock16,605$016,605D
Warrant for common stock$6.50407/06/2026A16,605(1) (2)01/06/2031Common stock16,605$016,605D
Warrant for common stock$7.04607/06/2026A16,605(1) (2)01/06/2031Common stock16,605$016,605D
Explanation of Responses:
1. Represents a one-time equity grant as part of the Reporting Person's non-management director compensation, effective July 6, 2026.
2. The warrants vest as follows: 25% of each tranche of the warrants become exercisable on January 6, 2027, 25% of each tranche of the warrants will become exercisable on July 6, 2027, 25% of each tranche of the warrants will become exercisable on January 6, 2028, and 25% of each tranche of the warrants will become exercisable on July 6, 2028.
/s/ Howard P. Liszt07/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)